113 related articles for article (PubMed ID: 36695093)
1. Comprehensive analysis of
Luo H; Jiang Q; Luo Y; Yang M; Yu Y; Yu C; Wang X
Epigenomics; 2022 Nov; 14(22):1393-1409. PubMed ID: 36695093
[No Abstract] [Full Text] [Related]
2. Identification of Hypoxia-Related Prognostic Signature and Competing Endogenous RNA Regulatory Axes in Hepatocellular Carcinoma.
Tang Y; Zhang H; Chen L; Zhang T; Xu N; Huang Z
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362375
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of GSEC/miR-101-3p/SNX16/PAPOLG axis in hepatocellular carcinoma.
Hu S; Zhang J; Guo G; Zhang L; Dai J; Gao Y
PLoS One; 2022; 17(4):e0267117. PubMed ID: 35482720
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of a TPX2-related TRHDE-AS1/PKIA ceRNA network involving prognostic signatures in Hepatitis B virus-infected hepatocellular carcinoma.
Li G; Wang Z; Chen D; Yin J; Mo Z; Sun B; Yang T; Zhang X; Zhai Z; Li Y; Chen P; Dai Y; Wang Z; Ma J
Front Cell Infect Microbiol; 2022; 12():1025900. PubMed ID: 36204642
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.
Zhang L; Tao H; Li J; Zhang E; Liang H; Zhang B
Aging (Albany NY); 2021 May; 13(12):15990-16008. PubMed ID: 34049287
[TBL] [Abstract][Full Text] [Related]
6. lncRNA-AC079061.1/VIPR1 axis may suppress the development of hepatocellular carcinoma: a bioinformatics analysis and experimental validation.
Lin XH; Zhang DY; Liu ZY; Tang WQ; Chen RX; Li DP; Weng S; Dong L
J Transl Med; 2022 Aug; 20(1):379. PubMed ID: 36038907
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of Competing Endogenous RNA Network Focusing on Long Noncoding RNA Involved in Cirrhotic Hepatocellular Carcinoma.
Zhang Y; Chen D; Yang M; Qian X; Long C; Zheng Z
Anal Cell Pathol (Amst); 2021; 2021():5510111. PubMed ID: 34258170
[TBL] [Abstract][Full Text] [Related]
8. Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.
Zhang Q; Sun L; Zhang Q; Zhang W; Tian W; Liu M; Wang Y
Cancer Med; 2020 Dec; 9(24):9219-9235. PubMed ID: 33232580
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of an immune-related ceRNA network in identifying a novel lncRNA signature as a prognostic biomarker for hepatocellular carcinoma.
Chen R; Chen Y; Huang W; Zhao Y; Luo W; Lin J; Wang Z; Yang J
Aging (Albany NY); 2021 Jul; 13(13):17607-17628. PubMed ID: 34237706
[TBL] [Abstract][Full Text] [Related]
10. Systemic analysis identifying PVT1/DUSP13 axis for microvascular invasion in hepatocellular carcinoma.
Su R; Zhang H; Zhang L; Khan AR; Zhang X; Wang R; Shao C; Wei X; Xu X
Cancer Med; 2023 Apr; 12(7):8937-8955. PubMed ID: 36524545
[TBL] [Abstract][Full Text] [Related]
11. Upregulated UBE4B expression correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma.
Shao X; Zhu J; Shi Y; Fang H; Chen J; Zhang Y; Wang J; Jian H; Lan S; Jiang F; Zhong F; Zhang Y; Cao C
Aging (Albany NY); 2022 Dec; 14(23):9632-9646. PubMed ID: 36470669
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of a ceRNA network reveals potential prognostic cytoplasmic lncRNAs involved in HCC progression.
Bai Y; Long J; Liu Z; Lin J; Huang H; Wang D; Yang X; Miao F; Mao Y; Sang X; Zhao H
J Cell Physiol; 2019 Aug; 234(10):18837-18848. PubMed ID: 30916406
[TBL] [Abstract][Full Text] [Related]
13. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
[TBL] [Abstract][Full Text] [Related]
14. CRNDE-h transcript/miR-136-5p axis regulates interleukin enhancer binding factor 2 expression to promote hepatocellular carcinoma cell proliferation.
Shiu TY; Lin HH; Shih YL; Feng AC; Huang HH; Huang TY; Hsieh CB; Chang WK; Hsieh TY
Life Sci; 2021 Nov; 284():119708. PubMed ID: 34153299
[TBL] [Abstract][Full Text] [Related]
15. Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma.
Zhou X; Dou M; Liu Z; Jiao D; Li Z; Chen J; Li J; Yao Y; Li L; Li Y; Han X
J Immunol Res; 2021; 2021():5518908. PubMed ID: 34426790
[TBL] [Abstract][Full Text] [Related]
16. Identification of microRNA hsa-miR-30c-5p as an inhibitory factor in the progression of hepatocellular carcinoma and investigation of its regulatory network via comprehensive analysis.
Hu S; Zhang J; Fang X; Guo G; Dai J; Sheng Z; Li D; Chen J; Zhang L; Liu C; Gao Y
Bioengineered; 2021 Dec; 12(1):7165-7177. PubMed ID: 34503377
[TBL] [Abstract][Full Text] [Related]
17. Integrated analysis of ceRNA network in hepatocellular carcinoma using bioinformatics analysis.
Luo Y; Li H; Huang H; Xue L; Li H; Liu L; Fu H
Medicine (Baltimore); 2021 Jun; 100(22):e26194. PubMed ID: 34087888
[TBL] [Abstract][Full Text] [Related]
18. Role of
Ming XL; Feng YL; He DD; Luo CL; Rong JL; Zhang WW; Ye P; Chai HY; Liang CZ; Tu JC
Epigenomics; 2019 Aug; 11(10):1209-1231. PubMed ID: 31339046
[No Abstract] [Full Text] [Related]
19. Comprehensive analysis of the MIR4435-2HG/miR-1-3p/MMP9/miR-29-3p/DUXAP8 ceRNA network axis in hepatocellular carcinoma.
Zhang L; Hu S; Chen J; Ma S; Liu F; Liu C; Gao Y
Discov Oncol; 2021 Oct; 12(1):38. PubMed ID: 35201491
[TBL] [Abstract][Full Text] [Related]
20. Reconstruction and Analysis of the Differentially Expressed IncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA in Hepatocellular Carcinoma.
Cao D; Wang Y; Li D; Wang L
Crit Rev Eukaryot Gene Expr; 2019; 29(6):539-549. PubMed ID: 32422009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]